You have 9 free searches left this month | for more free features.

City

Chengdu (1)

Condition

HNSCC (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

Sponsor

Sichuan Cancer Hospital and Research Institute (1)

Collaborator

Intervention

nituozumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

nituozumab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HNSCC Trial in Chengdu (Nituozumab)

Recruiting

HNSCC

Nituozumab

Chengdu, Sichuan, China

Sichuan Cancer Hospital and Research Institute

Apr 16, 2023